Dr. Bothwell is an ethicist and historian of public health. Her research examines social, historical, and ethical dimensions of epidemiology with a particular focus on randomized controlled trials (RCTs). Her current book project examines how international and national policies have influenced trial rigor and ethics, protections of vulnerable trial subjects, and participant diversity in RCTs. She also does work at the intersection of climate change, epidemiology, and ethics. She completed a PhD in the History and Ethics of Public Health and Medicine from the Department of Sociomedical Sciences at Columbia University followed by a postdoctoral fellowship in Health Policy, Law, and Ethics in the Division of Pharmacoepidemiology and Pharmacoeconomics at Harvard Medical School and the Brigham and Women’s Hospital. She has also had visiting appointments at Oxford University, Foundation Brocher, the Karolinska Institutet, and National Taiwan University. She teaches public health ethics and the history of public health, and provides pre-departure ethics training in global health practice. She holds a secondary appointment in the Section of the History of Medicine at the Yale School of Medicine.

Andrew Dewan is a genetic epidemiologist with a focus on extending and applying analytical methods to identify genetic susceptibility variants for complex traits. A key theme throughout his work is applying a strategy of delineating narrowly defined phenotypes and stratification by ancestry to reduce heterogeneity and increase statistical power. To better elucidate the genetic architecture of complex traits, his research extends analytical methods to identify genetic interactions as well as pleiotropy. He has applied these genetic mapping methods across a number of diverse phenotypes including asthma, obesity, leukemia, pediatric lung cancer, preeclampsia, preterm birth, and bacterial bloodstream infections. He has been the Principal Investigator of external grants to fund his research (5 NIH grants, including three R01s). He is the Director of the Yale Center for Perinatal, Pediatric and Environmental Epidemiology (CPPEE) which brings together diverse faculty with interests in the health of women and children through epidemiologic research investigating the impact of environmental, genetic and clinical factors on pregnancy, birth and childhood. He recently served a three-year term as a member of the Program Committee for the American Society of Human Genetics, the primary scientific organization for human geneticists worldwide. He has been able to incorporate my research interests through to my educational activities, teaching the course Genetic Concepts in Public Health, guest lecturing on genetic epidemiology and teaching at international courses for linkage and association analyses.

Katie Wang, Ph.D., is an assistant professor in the Department of Social and Behavioral Sciences at Yale School of Public Health. She received her Ph.D. in Social Psychology from Yale University and completed a postdoctoral fellowship through the Yale AIDS Prevention Training Program. Dr. Wang's research broadly focuses on the role of stigma as a psychosocial determinant of mental and behavioral health disparities among diverse marginalized populations. She received a K01 mentored scientist career development award from the National Institute on Drug Abuse to investigate the associations among mental illness stigma, emotion dysfunction (i.e., intense, prolonged negative affect and/or difficulties in regulating one's emotions), and substance use among adults with depression. She is also involved in a number of projects that examine the health inequities facing people with disabilities, including a longitudinal study on the mental health impact of the COVID-19 pandemic on people with disabilities. Dr. Wang utilizes a wide range of methodologies in her research, including surveys, experiments, psychophysiological measures, ecological momentary assessment, and qualitative interviews.